Ekso Bionics (NASDAQ:EKSO) Stock Price Passes Above 50-Day Moving Average of $1.54

Shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO – Get Rating) passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $1.54 and traded as high as $1.54. Ekso Bionics shares last traded at $1.48, with a volume of 52,097 shares.

Wall Street Analyst Weigh In

EKSO has been the subject of several recent analyst reports. StockNews.com initiated coverage on Ekso Bionics in a research note on Wednesday. They set a “sell” rating for the company. HC Wainwright reiterated a “buy” rating and set a $9.00 price objective on shares of Ekso Bionics in a research note on Thursday, March 30th. Finally, 500.com reiterated a “reiterates” rating on shares of Ekso Bionics in a research note on Friday, April 28th.

Ekso Bionics Stock Performance

The company has a market capitalization of $19.91 million, a price-to-earnings ratio of -1.31 and a beta of 1.80. The company has a debt-to-equity ratio of 0.17, a current ratio of 2.89 and a quick ratio of 2.30. The stock has a 50 day moving average price of $1.54 and a two-hundred day moving average price of $1.49.

Ekso Bionics (NASDAQ:EKSO – Get Rating) last announced its earnings results on Tuesday, March 28th. The company reported ($0.24) earnings per share for the quarter. Ekso Bionics had a negative net margin of 102.64% and a negative return on equity of 55.47%. The business had revenue of $3.55 million during the quarter. On average, analysts predict that Ekso Bionics Holdings, Inc. will post -1.27 EPS for the current fiscal year.

Institutional Trading of Ekso Bionics

A number of hedge funds and other institutional investors have recently made changes to their positions in EKSO. Dimensional Fund Advisors LP acquired a new position in shares of Ekso Bionics during the 3rd quarter worth about $28,000. Legato Capital Management LLC acquired a new position in shares of Ekso Bionics during the 4th quarter worth about $45,000. Strategic Wealth Investment Group LLC grew its position in shares of Ekso Bionics by 26.4% during the 4th quarter. Strategic Wealth Investment Group LLC now owns 28,336 shares of the company’s stock worth $46,000 after buying an additional 5,917 shares during the period. Renaissance Technologies LLC grew its position in shares of Ekso Bionics by 153.4% during the 2nd quarter. Renaissance Technologies LLC now owns 44,606 shares of the company’s stock worth $74,000 after buying an additional 27,006 shares during the period. Finally, Essex Investment Management Co. LLC grew its position in shares of Ekso Bionics by 90.7% during the 3rd quarter. Essex Investment Management Co. LLC now owns 319,673 shares of the company’s stock worth $499,000 after buying an additional 152,028 shares during the period. 12.74% of the stock is currently owned by institutional investors and hedge funds.

About Ekso Bionics

(Get Rating)

Ekso Bionics Holdings, Inc engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following segments: EksoHealth and EksoWorks. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets.